Difference between revisions of "Example orders for Cetuximab (Erbitux) in colon cancer"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth" to "{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" | <span style="font-family:Arial; font-size:200%"> Hello!<br>  We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br>  Please help us by filling it out!<br>  '''Link:''' http://j.mp/2BlBaoQ </span> |}<br>'''Use of this site is subject to you reading and agreeing with the terms set forth")
m (Text replacement - "font-size:200%"> Hello!<br>  We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br>  Please help us by filling it out!<br>" to "font-size:300%"> Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>")
Line 1: Line 1:
 
{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center"  
 
{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center"  
 
|
 
|
<span style="font-family:Arial; font-size:200%">&nbsp;Hello!<br>
+
<span style="font-family:Arial; font-size:300%">&nbsp;Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.<br>
&nbsp;We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br>
 
&nbsp;Please help us by filling it out!<br>
 
 
&nbsp;'''Link:''' http://j.mp/2BlBaoQ
 
&nbsp;'''Link:''' http://j.mp/2BlBaoQ
 
</span>
 
</span>

Revision as of 03:34, 23 January 2018

 Just 10 days left to fill out a survey on how we can make HemOnc.org better and more useful.
 Link: http://j.mp/2BlBaoQ


Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.

Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.


Cetuximab (Erbitux)

Original references may be found at Cetuximab (Erbitux)

Example regimen #1

For cycle 1:

28-day cycle

Supportive medications

  • Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to cetuximab
  • Diphenhydramine (Benadryl) 50 mg IV 30 minutes prior to cetuximab

Hydration:

  • 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.

Monitoring:

  • Hold if ANC <1000 or platelets <100 and notify physician.

For cycle 2 and later:

  • Cetuximab (Erbitux) 250 mg/m2 IV over 60 minutes on days 1, 8, 15, 22
    • Use non-DEHP/paclitaxel tubing.

28-day cycles

Supportive medications

  • Acetaminophen (Tylenol) 650 mg PO 30 minutes prior to cetuximab
  • Diphenhydramine (Benadryl) 50 mg IV 30 minutes prior to cetuximab

Hydration:

  • 500 ml NS at KVO rate as running IV for chemotherapy infusion. Give up to 500 ml NS.

Monitoring:

  • Hold if ANC <1000 or platelets <100 and notify physician.

Comments:

  • My institution uses 28-day cycles for Cetuximab (Erbitux) regimens.